Proteasomes are a target of the anti-tumour drug vinblastine

Biochemical Journal

Volumn 356, Issue 3, 2001, Pages 835-841

  Piccinini, M ^a   Tazartes, O ^a   Mezzatesta, C ^a   Ricotti, E ^a   Bedino, S ^a   Grosso, F ^a   Dianzani, U ^a   Tovo, P A ^a   Mostert, M ^a   Musso, A ^a   Rinaudo, M T ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Cytostatic agents; Leukaemic cells; Proteolysis; Ubiquitin conjugates

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHYMOTRYPSIN; LYSOZYME; PEPTIDASE; PEPTIDE; PROTEASOME; TRYPSIN; UBIQUITIN; VINBLASTINE;

APOPTOSIS; ARTICLE; ASSAY; CELL CYCLE; CELL VIABILITY; CONTROLLED STUDY; CYTOSTASIS; DOSE RESPONSE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYDROLYSIS; LEUKEMIA; LEUKEMIA CELL; MITOSIS SPINDLE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; TARGET CELL; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CATALYSIS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HL-60 CELLS; HUMANS; MULTIENZYME COMPLEXES; PROTEASOME ENDOPEPTIDASE COMPLEX; VINBLASTINE;

EID: 0035875527     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3560835     Document Type: Article

References (45)

1. Pathways of ubiquitin conjugation
2. Regulating protein degradation by ubiquitination
3. The ubiquitin-proteasome pathway and pathogenesis of human diseases
4. Structure and functions of the 20S and 26S proteasomes
5. The proteasome: Paradigm of a self-compartmentalizing protease
6. Identification of the yeast 20S proteasome catalytic centers and subunit interactions required for active-site formation
7. The base of the proteasome regulatory particle exhibits cheperone-like activity
8. The proteasome activator 11 S REG (PA28) and class 1 antigen presentation
9. How proteolysis drives the cell cycle
10. How the ciclin became a cyclin: Regulated proteolysis in the cell cycle
11. Cell cycle regulation by the ubiquitin pathway
12. The ubiquitin-proteasome pathway in cancer
13. Proteasome inhibitors: Valuable new tools for cell biologists
14. Cytotoxic effects of cell cycle phase specific agents: Result of cell cycle perturbation
15. Structural insights into microtubule function
16. Mechanism of inhibition of cell proliferation by Vinca alkaloids
17. Mechanism of action and of resistance to antitubulin agents: Microtubule dynamics, drug transport, and cell death
18. The antitumor drug aclacinomycin A, which inhibits the degradation of ubiquitinated proteins, shows selectivity for the chymotrypsin-like activity of the bovine pituitary 20S proteasome
19. An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses
20. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κ B
21. Multiple forms of the 20S multicatalytic and the 26S ubiquitin/ATP-dependent proteases from rabbit reticulocyte lysate
22. Structural and functional characterization of 20S and 26S proteasomes from bovine brain
23. Purification of an 11S regulator of the multicatalytic protease
24. Ubiquitin lysozyme conjugates: Purification and susceptibility to proteolysis
25. Biochemical reagents for general use
26. Autolysis of human erythrocyte calpain produces two active enzyme forms with different cell localization
27. A general strategy for parameter estimation from isosteric and allosteric kinetic data and binding measurements
28. Determination of Michaelis constants and inhibitor constants
29. 4
30. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
31. Affinity purification and characterization of protein gene product 9.5 (PGP 9.5) from retina
32. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
33. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation
34. Differential cellular retention of vincristine and vinblastine by cultured human promyelocytic leukemia HL-60/Cl cells: The basis of differential toxicity
35. Cellular pharmacokinetics of vinblastine and other vinca alkaloids in MO4 cells
36. Cellular uptake and tubulin binding properties of four vinca alkaloids
37. Kinetic characterization of the chymotryptic activity of the 20S proteasome
38. The NF-κB and IκB proteins: New discoveries and insights
39. Inhibition of the proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin
40. Cyclosporin A is an uncompetitive inhibitor of proteasome activity and prevents NF-κB activation
41. Cell cycle control by ubiquitin-dependent proteolysis
42. Separating sister chromatids
43. Cdc20 promotes exit from mitosis by destroying the anaphase inhibitor Pds1 and cyclin CIb5
44. Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis
45. NF-κB: Ten years after